最高の網膜幹細胞治療医師 - トップ8名の医師

Dr. Muhammet Derda Ozer is an associate professor and ophthalmologist at his JCI-accredited clinic in Istanbul. He completed a fellowship in vitreo-retina at the University of Kansas Medical School. Dr. Ozer has performed over 25,000 surgical procedures during his clinical practice. He holds the Advanced Examination certificate from the International Council of Ophthalmology.

• Specializes in cataract surgery, refractive laser vision correction, and retina care.
• Treats complex conditions including ocular oncology and pediatric retinoblastoma.
• Passed USMLE Step 1 and Step 2 CK for US medical licensure.
• Active member of the Young Ophthalmologist Council within the Turkish Ophthalmological Association.

Dr. Yasar Dag is an ophthalmologist at VM Medical Park Florya Hospital in Istanbul. He specializes in cataract surgery, corneal diseases, and strabismus. Dr. Dag previously served as a specialist at Basaksehir Cam and Sakura City Hospital. He is a member of the Turkish Ophthalmological Association.

• Performs corneal transplants, keratoplasty, and ocular trauma surgery.
• Completed vitrectomy training at Ulucanlar Eye Training and Research Hospital.
• Published over 10 research papers on tear film analysis and surgical margins.
• Works at a JCI-accredited university hospital with robotic and bariatric excellence centers.

Dr. Yasar Dag is an ophthalmologist at Valued Med Hub Hospitals in Istanbul. He specializes in cataract surgery and corneal transplant procedures. Dr. Dag completed vitrectomy training at Ulucanlar Eye Training and Research Hospital. He treats complex conditions like strabismus, glaucoma, and retinopathy of prematurity.

• Member of the Turkish Ophthalmology Association (TOD).
• Performs LASIK, ReLEx SMILE, and femtosecond laser procedures.
• Authored over 10 publications in journals like BMC Ophthalmology.
• Expert in eyelid, lacrimal duct, and eye trauma surgery.

Dr. Ali Riza Cenk Celebi is an ophthalmologist at İstinye University Liv Hospital Topkapı. He completed a glaucoma fellowship at Harvard Medical School. Dr. Celebi authored over 50 international articles and 15 books. He ranked 11th out of all medical graduates in Turkey's specialty exam.

• Specializes in scarless endoscopic lacrimal surgery and limbal stem cell transplantation.
• Performs minimally invasive glaucoma surgery (MIGS) and seton implant procedures.
• Hold certifications from the International Council of Ophthalmology (ICO) and FEBO.
• Manages myopia progression in children using specialized lenses.

Dr. Bujar Rizvanolli is an ophthalmologist at the Italian Eye Hospital in Pristina. He specializes in touchless TransPRK and corneal cross-linking for keratoconus. He trained at the University Clinical Center of Sarajevo. Dr. Rizvanolli focuses on laser vision correction for patients with thin corneas. He works at the first clinic in Kosovo to offer TransPRK SmartSurface technology.

• Performs non-invasive surface ablation to correct myopia, hyperopia, and astigmatism.
• Treats progressive corneal diseases using laser-assisted cross-linking protocols.
• Expert in therapeutic laser procedures and keratoconus diagnosis.
• Educates the public on eye disease prevention through health campaigns.

Dr. Matin Suleymanzade is an ophthalmologist and eye surgeon at Biruni University Hospital in Istanbul. He is certified by the International Council of Ophthalmology (ICO). Dr. Suleymanzade specializes in refractive surgery, cataract removal, and oculoplastic procedures. He treats complex conditions like keratoconus, uveitis, and glaucoma.

• Holds multiple ICO certifications in basic science, optics, and refraction.
• Performs specialized procedures including vitrectomy and retinal detachment surgery.
• Member of the Turkish Ophthalmology Association (TOD).
• Works at a TEMOS-accredited university hospital equipped with 15 operating rooms.

Dr. Sean Hu is a leader in biotechnology and stem cell therapy. He earned a PhD in biochemistry and molecular biology from the University of Gothenburg and Chalmers University of Technology in Sweden. He is the founder, chairman, and CEO of Shenzhen Beike Biotechnology Co., Ltd. He also serves as director of the Shenzhen Beike Cell Engineering Institute.

He was among the first experts recognized by China’s Thousand Talents Program. At Beike, he leads the development and commercialization of adult stem cell therapies. His work focuses on conditions of the brain and spinal cord, and on neurodegenerative and autoimmune disorders. His goal is to make high-quality care more accessible.